Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Citi
Farmers Insurance
UBS
McKinsey
McKesson

Generated: July 17, 2019

DrugPatentWatch Database Preview

Patent: 9,877,962

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,877,962
Title:Piperazinyl derivatives for the treatment of cancer
Abstract: Piperazinyl derivatives of formula (I) and their use as a drug, particularly for the treatment of cancer, are disclosed. Also disclosed are pharmaceutical compositions comprising the piperazinyl derivatives, and methods for synthesizing the piperazinyl derivatives.
Inventor(s): Carniato; Denis (Marcoussis, FR), Briand; Jean-Francois (Saclay, FR), Gutmann; Mathieu (Vaugrigneuse, FR), Busnel; Olivier (Allennes les Marais, FR), Bougeret; Cecile (Nevers, FR), Deprez; Benoit (Lille, FR), Jaillardon; Karine (Saint Michel s/Orge, FR)
Assignee: Pitty; Marc Henry (Boulogne-Billancourt, FR)
Application Number:15/135,994
Patent Claims:see list of patent claims

Details for Patent 9,877,962

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech PERJETA pertuzumab VIAL; SINGLE-USE 125409 001 2012-06-08 ➤ Sign Up Pitty; Marc Henry (Boulogne-Billancourt, FR) ➤ Sign Up RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up Pitty; Marc Henry (Boulogne-Billancourt, FR) ➤ Sign Up RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up Pitty; Marc Henry (Boulogne-Billancourt, FR) ➤ Sign Up RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Sign Up Pitty; Marc Henry (Boulogne-Billancourt, FR) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Argus Health
Baxter
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.